The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party ( ALWP ) of the European group for blood and marrow transplantation (EBMT)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (
ALWP
) of the
European group for blood and marrow transplantation (EBMT)
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-18
DOI
10.1002/ajh.26000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia
- (2019) Jonathan Canaani et al. LEUKEMIA
- Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of EBMT acute leukemia Working Party
- (2019) Ali Bazarbachi et al. HAEMATOLOGICA
- Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT
- (2019) Giorgia Battipaglia et al. BONE MARROW TRANSPLANTATION
- Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT.
- (2019) Xavier Poiré et al. HAEMATOLOGICA
- Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
- (2019) Francesco Saraceni et al. Journal of Hematology & Oncology
- Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT
- (2019) Frédéric Baron et al. Blood Cancer Journal
- Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin
- (2019) Frédéric Baron et al. HAEMATOLOGICA
- Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia
- (2018) Giorgia Battipaglia et al. BONE MARROW TRANSPLANTATION
- Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center
- (2018) Stefan O. Ciurea et al. CANCER
- Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: A report of 1578 patients from the Acute Leukemia Working Party of EBMT
- (2018) Eolia Brissot et al. HAEMATOLOGICA
- Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- (2016) Michael Byrne et al. EXPERIMENTAL HEMATOLOGY
- Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study
- (2016) Annalisa Ruggeri et al. Journal of Hematology & Oncology
- Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
- (2016) Nicolaus Kröger et al. NEW ENGLAND JOURNAL OF MEDICINE
- How I treat refractory and early relapsed acute myeloid leukemia
- (2015) F. Thol et al. BLOOD
- Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission
- (2015) A Ruggeri et al. BONE MARROW TRANSPLANTATION
- Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis
- (2015) Arnon Nagler et al. Lancet Haematology
- Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia
- (2014) B. C. Medeiros et al. HAEMATOLOGICA
- Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience
- (2010) B. C. Medeiros et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now